{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T13:02:14Z","timestamp":1776258134357,"version":"3.50.1"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T00:00:00Z","timestamp":1773187200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T00:00:00Z","timestamp":1773187200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Hematol"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1007\/s12185-026-04188-0","type":"journal-article","created":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T04:17:05Z","timestamp":1773202625000},"page":"516-520","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Efficacy and safety of romiplostim with horse anti-thymocyte globulin and cyclosporine in acquired aplastic anemia"],"prefix":"10.1007","volume":"123","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1025-1201","authenticated-orcid":false,"given":"Shuku","family":"Sato","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emi","family":"Sawazaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shun","family":"Tsunoda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wataru","family":"Kamata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomiteru","family":"Togano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yotaro","family":"Tamai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryuji","family":"Tanosaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,11]]},"reference":[{"issue":"16","key":"4188_CR1","doi-asserted-by":"publisher","first-page":"1540","DOI":"10.1056\/NEJMoa1613878","volume":"376","author":"DM Townsley","year":"2017","unstructured":"Townsley DM, Scheinberg P, Winkler T, Desmond R, Dumitriu B, Rios O, et al. Eltrombopag added to standard immunosuppression for aplastic anemia. N Engl J Med. 2017;376(16):1540\u201350.","journal-title":"N Engl J Med"},{"issue":"21","key":"4188_CR2","doi-asserted-by":"publisher","first-page":"4192","DOI":"10.1002\/cncr.31658","volume":"124","author":"R Assi","year":"2018","unstructured":"Assi R, Garcia-Manero G, Ravandi F, Borthakur G, Daver NG, Jabbour E, et al. Addition of eltrombopag to immunosuppressive therapy in patients with newly diagnosed aplastic anemia. Cancer. 2018;124(21):4192\u2013201.","journal-title":"Cancer"},{"issue":"1","key":"4188_CR3","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1056\/NEJMoa2109965","volume":"386","author":"R Peffault de Latour","year":"2022","unstructured":"Peffault de Latour R, Kulasekararaj A, Iacobelli S, Terwel SR, Cook R, Griffin M, et al. Eltrombopag added to immunosuppression in severe aplastic anemia. N Engl J Med. 2022;386(1):11\u201323.","journal-title":"N Engl J Med"},{"issue":"1","key":"4188_CR4","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1056\/NEJMoa1200931","volume":"367","author":"MJ Olnes","year":"2012","unstructured":"Olnes MJ, Scheinberg P, Calvo KR, Desmond R, Tang Y, Dumitriu B, et al. Eltrombopag and improved hematopoiesis in refractory severe aplastic anemia. N Engl J Med. 2012;367(1):11\u20139.","journal-title":"N Engl J Med"},{"issue":"8","key":"4188_CR5","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1056\/NEJMct1014202","volume":"365","author":"P Imbach","year":"2011","unstructured":"Imbach P, Crowther M. Thrombopoietin-receptor agonists for primary immune thrombocytopenia. N Engl J Med. 2011;365(8):734\u201341.","journal-title":"N Engl J Med"},{"issue":"Suppl 1","key":"4188_CR6","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1007\/s00277-010-0953-x","volume":"89","author":"T K\u00fchne","year":"2010","unstructured":"K\u00fchne T, Imbach P. Eltrombopag: an update on the novel, non-peptide thrombopoietin receptor agonist for the treatment of immune thrombocytopenia. Ann Hematol. 2010;89(Suppl 1):67\u201374.","journal-title":"Ann Hematol"},{"issue":"6","key":"4188_CR7","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1007\/s12185-020-02971-1","volume":"112","author":"M Ise","year":"2020","unstructured":"Ise M, Iizuka H, Kamoda Y, Hirao M, Kida M, Usuki K. Romiplostim is effective for eltrombopag-refractory aplastic anemia: results of a retrospective study. Int J Hematol. 2020;112(6):787\u201394.","journal-title":"Int J Hematol"},{"issue":"3","key":"4188_CR8","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1038\/s41375-020-0950-6","volume":"35","author":"K Hosokawa","year":"2021","unstructured":"Hosokawa K, Yamazaki H, Tanabe M, Imi T, Sugimori N, Nakao S. High\u2011dose romiplostim accelerates hematologic recovery in patients with aplastic anemia refractory to eltrombopag. Leukemia. 2021;35(3):906\u20139.","journal-title":"Leukemia"},{"issue":"2","key":"4188_CR9","first-page":"92","volume":"66","author":"S Sato","year":"2025","unstructured":"Sato S, Tsunoda S, Kamata W, Togano T, Tamai Y. Efficacy and safety of romiplostim in aplastic anemia refractory or intolerant to immunosuppressive therapy with eltrombopag. Rinsho Ketsueki. 2025;66(2):92\u20139.","journal-title":"Rinsho Ketsueki"},{"key":"4188_CR10","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2024014855","author":"JW Lee","year":"2025","unstructured":"Lee JW, Jang JH, Yamazaki H, Sawa M, Kizaki M, Tomiyama Y, et al. Addition of romiplostim to immunosuppressive therapy as first-line treatment for patients with aplastic anemia. Blood Adv. 2025. https:\/\/doi.org\/10.1182\/bloodadvances.2024014855.","journal-title":"Blood Adv"},{"issue":"2","key":"4188_CR11","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1111\/bjh.20206","volume":"207","author":"JW Lee","year":"2025","unstructured":"Lee JW, Jang JH, Chiba S, Yoon SS, Oshikawa G, Usuki K, et al. Romiplostim with ciclosporin A in patients with aplastic anaemia na\u00efve to immunosuppressive therapy: a phase 2\/3 study. Br J Haematol. 2025;207(2):582\u201390.","journal-title":"Br J Haematol"},{"issue":"4","key":"4188_CR12","volume":"15","author":"G Dhingra","year":"2023","unstructured":"Dhingra G, Rajoreya A. A single-centre experience of first-line romiplostim and immunosuppressive therapy in patients with aplastic anemia. Cureus. 2023;15(4):e37682.","journal-title":"Cureus"},{"issue":"3","key":"4188_CR13","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1111\/bjh.19236","volume":"204","author":"A Kulasekararaj","year":"2024","unstructured":"Kulasekararaj A, Cavenagh J, Dokal I, Foukaneli T, Gandhi S, Garg M, et al. BSH committee. Guidelines for the diagnosis and management of adult aplastic anaemia: a British Society for Haematology Guideline. Br J Haematol. 2024;204(3):784\u2013804.","journal-title":"Br J Haematol"},{"key":"4188_CR14","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1038\/bmt.2012.244","volume":"48","author":"Y Kanda","year":"2013","unstructured":"Kanda Y. Investigation of the freely available easy-to-use software \u2018EZR\u2019 for medical statistics. Bone Marrow Transplant. 2013;48:452\u20138.","journal-title":"Bone Marrow Transplant"},{"issue":"4","key":"4188_CR15","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1111\/bjh.12661","volume":"164","author":"A Kulagin","year":"2014","unstructured":"Kulagin A, Lisukov I, Ivanova M, Golubovskaya I, Kruchkova I, Bondarenko S, et al. Prognostic value of paroxysmal nocturnal haemoglobinuria clone presence in aplastic anaemia patients treated with combined immunosuppression: results of two-centre prospective study. Br J Haematol. 2014;164(4):546\u201354.","journal-title":"Br J Haematol"},{"issue":"5","key":"4188_CR16","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1056\/NEJMoa1103975","volume":"365","author":"P Scheinberg","year":"2011","unstructured":"Scheinberg P, Nunez O, Weinstein B, Scheinberg P, Biancotto A, Wu CO, et al. Horse versus rabbit antithymocyte globulin in acquired aplastic anemia. N Engl J Med. 2011;365(5):430\u20138.","journal-title":"N Engl J Med"},{"issue":"1","key":"4188_CR17","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1182\/blood.2021012130","volume":"139","author":"BA Patel","year":"2022","unstructured":"Patel BA, Groarke EM, Lotter J, Shalhoub R, Gutierrez-Rodrigues F, Rios O, et al. Long-term outcomes in patients with severe aplastic anemia treated with immunosuppression and eltrombopag: A phase 2 study. Blood. 2022;139(1):34\u201343.","journal-title":"Blood"},{"issue":"6","key":"4188_CR18","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1182\/bloodadvances.2023010959","volume":"8","author":"K Mitani","year":"2024","unstructured":"Mitani K, Lee JW, Jang JH, Tomiyama Y, Miyazaki K, Nagafuji K, et al. Long-term efficacy and safety of romiplostim in refractory aplastic anemia: follow-up of a phase 2\/3 study. Blood Adv. 2024;8(6):1415\u20139.","journal-title":"Blood Adv"},{"issue":"5","key":"4188_CR19","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1007\/s12185-024-03853-6","volume":"120","author":"Y Tezuka","year":"2024","unstructured":"Tezuka Y, Doe J, Smith A, et al. Expansion effect of romiplostim on hematopoietic stem and progenitor cells versus recombinant human TPO, partially distinct from eltrombopag in gene expression induction. Int J Hematol. 2024;120(5):575\u201386.","journal-title":"Int J Hematol"},{"issue":"1","key":"4188_CR20","first-page":"11","volume":"42","author":"Y Shida","year":"2011","unstructured":"Shida Y. Pharmacokinetics and pharmacodynamics of eltrombopag in healthy Japanese males. J Clin Pharmacol Ther. 2011;42(1):11\u20138.","journal-title":"J Clin Pharmacol Ther"}],"container-title":["International Journal of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-026-04188-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12185-026-04188-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-026-04188-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T11:56:39Z","timestamp":1776254199000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12185-026-04188-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,11]]},"references-count":20,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["4188"],"URL":"https:\/\/doi.org\/10.1007\/s12185-026-04188-0","relation":{},"ISSN":["0925-5710","1865-3774"],"issn-type":[{"value":"0925-5710","type":"print"},{"value":"1865-3774","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,11]]},"assertion":[{"value":"25 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 February 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 February 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 March 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}